Clinical Trial Update: Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating weekly oxaliplatin and gemcitabine for recurrent or metastatic head and neck cancer. The study was terminated and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Sai-Hong Ignatius Ou | Conditions: Cancer of the Head and Neck | Phase 2 | Status: TERMINATED | Results posted: 2014-04-25